Status:
ACTIVE_NOT_RECRUITING
Treating Primary Progressive Aphasia and Apraxia of Speech Using Non-invasive Brain Stimulation
Lead Sponsor:
The University of Texas at Dallas
Conditions:
Primary Progressive Aphasia
Apraxia of Speech
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
The purpose of the study is to test whether low level electric stimulation, called transcranial Direct Current Stimulation (tDCS), on the part of the brain (i.e., pre-supplementary motor area and left...
Detailed Description
This pilot study has one treatment arm with open-label treatment and will examine improvement of speech output, verbal fluency, and other cognitive deficits associated with primary progressive aphasia...
Eligibility Criteria
Inclusion
- 18 to 85 years of age
- A formal diagnosis of primary progressive aphasia (nonfluent/agrammatic, semantic, logopenic variants or mixed) and/or progressive apraxia of speech
- Capable of understanding and signing an informed consent. Medical information/history, as well as mental status exam and diagnosis provided by referring physician will determine whether or not a caregiver is required to be involved during this process.
Exclusion
- Has an implanted device, such as a pacemaker, metallic cranial implant, or a neurostimulator
- Skull defects
- Pregnant
- A significant history of arrhythmia or epileptic seizures.
- Not a native English speaker
- Currently receiving speech-language intervention
- Unable to communicated verbally
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 16 2026
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT05368350
Start Date
June 1 2022
End Date
April 16 2026
Last Update
May 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Texas at Dallas
Dallas, Texas, United States, 75235